Skip to main content
AIBD Regionals Main banner

Full Schedule

  1. Home
  2. Full Schedule

Full Schedule

  • Thursday, April 20, 2023
  • 12:00 PM – 12:15 PM .
    Welcome
  • 12:15 PM – 1:00 PM .
    Session I: 2023 Updates in IBD Management

    Speaker: Millie D. Long, MD, MPH, FACG – University of North Carolina at Chapel Hill

    Speaker: Florian Rieder, MD – Cleveland Clinic

  • 1:15 PM – 2:15 PM .
    Non-CME Innovation Theater
  • 2:30 PM – 3:15 PM .
    Session II: Advances in Fistulizing Crohn’s Disease: Emerging Therapies and Patient-Centric Management Strategies

    Speaker: Stefan D. Holubar, MD, MS, FACS, FASCRS (he/him/his) – Cleveland Clinic

  • 3:30 PM – 4:30 PM .
    Non-CME Innovation Theater
  • 4:45 PM – 5:30 PM .
    Session III: Strategies to Address Barriers and Optimize Outcomes in Luminal Crohn’s Disease

    Speaker: Florian Rieder, MD – Cleveland Clinic

  • Friday, April 21, 2023
  • 8:00 AM – 8:15 AM .
    Welcome
  • 8:15 AM – 9:00 AM .
    Session IV: Special Situations in UC

    Speaker: Raymond K. Cross, Jr., MD, MS, AGAF, FACG – University of Maryland School of Medicine

    Speaker: David T. Rubin, MD, FACG (he/him/his) – University of Chicago Medicine

  • 9:15 AM – 10:00 AM .
    Session V: Optimized Care for Patients With IBD: The Potential Benefits of Interleukin Inhibitors

    Speaker: Gil Y. Melmed, MD, MS, FACG, AGAF – Cedars-Sinai Medical Center

  • 10:15 AM – 11:15 AM .
    Non-CME Innovation Theater
  • 11:30 AM – 12:15 PM .
    Session VI: Optimizing Existing Therapies in the Management of IBD

    Speaker: Jessica R. Allegretti, MD,MPH, FACG, AGAF – Brigham and Women's Hospital, Harvard Medical School

  • 12:30 PM – 1:15 PM .
    Session VII: Utilizing our Therapeutic Armamentarium: Right Patient/Right Drug

    Speaker: David T. Rubin, MD, FACG (he/him/his) – University of Chicago Medicine

    Speaker: Florian Rieder, MD – Cleveland Clinic

  • 1:30 PM – 2:30 PM .
    Non-CME Innovation Theater
  • 2:45 PM – 3:30 PM .
    Session VIII: Harnessing the Utility of Selective Sphingosine 1-Phosphate Receptor Modulators to Optimize Patient Care in IBD

    Speaker: Raymond K. Cross, Jr., MD, MS, AGAF, FACG – University of Maryland School of Medicine

  • 3:45 PM – 4:30 PM .
    Session IX: Increasing Access to Improve Outcomes: Exploring the Role of Biosimilars in the Management of Inflammatory Bowel Disease

    Speaker: Christina Y. Ha, MD, FACG, AGAF – Mayo Clinic Scottsdale

  • 4:45 PM – 5:30 PM .
    Session X: Putting Your Knowledge to the Test: Challenging IBD cases

    Speaker: Gil Y. Melmed, MD, MS, FACG, AGAF – Cedars-Sinai Medical Center

    Panelist: Millie D. Long, MD, MPH, FACG – University of North Carolina at Chapel Hill

    Panelist: Florian Rieder, MD – Cleveland Clinic

    Panelist: Christina Y. Ha, MD, FACG, AGAF – Mayo Clinic Scottsdale